Skip to content

Construction of specific disease cohort of Chinese Male Breast Cancer (CSBrS-020)

Construction of specific disease cohort of Chinese Male Breast Cancer (CSBrS-020)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094868
Enrollment
Unknown
Registered
2024-12-30
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

male breast cancer

Interventions

Case series:None

Sponsors

The Second Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Men aged >=18 years; (2) Clearly invasive breast cancer by puncture biopsy or surgical pathology immunohistochemistry; (3) Eastern Coopreative Oncology Group (ECOG) performance status <=2; (5) Have complete clinicopathologic data and follow-up information; (6) Agreement of participants and signing of an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Breast metastases from primary tumors in other organs; (2) Extensive metastatic, symptomatic, visceral spread with short-term risk of life-threatening complications; (3) Comorbidities with other serious diseases, such as cardiovascular and cerebrovascular diseases, hepatic and renal insufficiency; (4) Previous history of psychiatric illness or cognitive impairment, unable to cooperate with the study; (5) Inability to complete follow-up or incomplete information; (6) Patients who have received previous tumor-related systemic therapy;

Design outcomes

Primary

MeasureTime frame
Overall Survival;Disease-free Survival;

Secondary

MeasureTime frame
Objective Remission Rate;Disease control rate;Adverse Clinical Reaction Ratio;

Countries

China

Contacts

Public ContactSong Ailin

The Second Hospital of Lanzhou University

songail@lzu.edu.cn+86 139 1939 0860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026